Alkermes Files 8-K: Director Changes & Compensation Updates

TL;DR

Alkermes 8-K: Director shuffle and pay changes filed May 31.

AI Summary

Alkermes plc. filed an 8-K on May 31, 2024, reporting on the departure of a director, election of new directors, and changes in officer compensation. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.

Why It Matters

This filing signals potential shifts in the company's leadership and governance structure, which could influence strategic decisions and investor confidence.

Risk Assessment

Risk Level: low — The filing is routine and reports on standard corporate governance matters without indicating immediate financial distress or significant operational changes.

Key Players & Entities

• Alkermes plc. (company) — Registrant
• May 31, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.01 — on which registered Ordinary shares, $0.01 par value ALKS Nasdaq Global Select

Filing Documents

• alks-20240531.htm (8-K) — 81KB
• alks-ex10_1.htm (EX-10.1) — 132KB
• 0000950170-24-067296.txt ( ) — 361KB
• alks-20240531.xsd (EX-101.SCH) — 30KB
• alks-20240531_htm.xml (XML) — 5KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On May 31, 2024, the Company held its Annual Meeting. The final voting results for the Annual Meeting are as follows: 1. By separate resolutions, shareholders elected the following directors, each to serve for a one-year term expiring at the Company's 2025 annual general meeting of shareholders, or until their respective successor is elected and shall qualify, with the votes cast as follows: For: Against: Abstain: Broker Non-Votes: Emily Peterson Alva 148,878,083 3,728,150 52,191 7,087,756 Shane M. Cooke 150,519,525 2,079,549 59,350 7,087,756 David A. Daglio, Jr. 150,505,739 2,089,011 63,674 7,087,756 Richard B. Gaynor, M.D. 149,041,351 3,555,861 61,212 7,087,756 Cato T. Laurencin, M.D., Ph.D. 146,576,835 5,878,419 203,170 7,087,756 Nancy S. Lurker 151,735,161 867,602 55,661 7,087,756 Brian P. McKeon 150,954,383 1,645,383 58,658 7,087,756 Richard F. Pops 145,600,915 6,558,087 499,422 7,087,756 Nancy L. Snyderman, M.D. 145,302,464 7,288,913 67,047 7,087,756 Frank Anders Wilson 149,588,895 3,012,367 57,162 7,087,756 Christopher I. Wright, M.D., Ph.D. 146,591,491 5,871,999 194,934 7,087,756 2. Shareholders approved, in a non-binding, advisory vote, the compensation of the Company's named executive officers, with the votes cast as follows: 149,795,702 votes for; 2,358,534 votes against; 504,188 votes abstaining; and 7,087,756 broker non-votes. 3. Shareholders approved, in a non-binding, advisory vote, the 1 Year' option for the frequency of future advisory votes on the compensation of the Company's named executive officers, with the votes cast as follows: 149,981,231 votes for the 1 Year' option; 16,253 votes for the 2 Year' option; 2,531,059 votes for the 3 Year' option; 129,881 votes abstaining; and 7,087,756 broker non-votes. Based on these results, and consistent with the recomm

01 Financial Sta tements and Exhibits

Item 9.01 Financial Sta tements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 10.1 Alkermes plc 2018 Stock Option and Incentive Plan, as amended. 104 Cover page interactive data file (embedded within the Inline XBRL document). 3 SIGNA TURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALKERMES PLC Date: May 31, 2024 By: /s/ David J. Gaffin David J. Gaffin Secretary 4